Louisiana was one of 13 states that filed individual suits in state courts over allegations that Lilly pushed Zyprexa for
uses that had not been approved by federal regulators.
Four-year agreement to provide engines for tanker aircraft is the latest military contract snared by Rolls-Royce’s local operations.
Eli Lilly and Co. can be certain of its exclusive rights to sell its cancer drug Gemzar for at least another
seven months. After that, who knows? The U.S. District Court for the Southern District of Indiana last week upheld the validity
of Lilly’s compound patent on Gemzar. But the court said Indianapolis-based Lilly could not enforce a second patent
on the drug until a court challenge plays out. That patent, related to the particular way Gemzar is used, was declared invalid
last year by a federal court in Michigan. Lilly's appeal of the Michigan ruling to the Court of Appeals for the Federal
Circuit will be heard on May 7. At stake is another three years of exclusive sales of Gemzar, if Lilly’s second patent
is upheld.
Indianapolis-based OneAmerica Financial Partners Inc. is edging further into the employee-benefits market.
The company’s American United Life Insurance Co. will now offer vision and dental insurance to its employer customers.
AUL won’t underwrite the insurance itself, instead hawking policies from Minnesota-based Security Life Insurance Company
of America. AUL will act as the third-party administrator for the policies it sells. AUL already offers disability, medical
stop-loss and group life insurance to employers.
Purdue University's Healthcare Technical Assistance Program has named Monica Arrowsmith director of
a new center to help Indiana primary-care doctors adopt electronic record and e-prescribing technology. Arrowsmith is heading
the Indiana Health Information Technology Extension Center (I-HITEC), funded by $12 million in stimulus funds via a federal
grant. Purdue’s center, one 70 nationwide to receive stimulus funds, will help small practices of 10 or fewer health
care providers select and implement new information technology. Arrowsmith was chief quality officer and legal counsel for
Clarian Arnett Health in Lafayette.
IUPUI is offering a new online graduate certificate program in clinical informatics to help local health
care providers use the information provided by electronic medical record systems to improve their practices. The certificate
can be gained by taking six courses available in the evening and accessible through online distance education. Applicants
must have clinical backgrounds, be licensed and hold a four-year degree from an accredited institution.
Dozens of people in the Indianapolis area have the potential and the interest to become angel investors in the next few years.
A wave of up-and-coming angel investors in the Indianapolis area are quietly accumulating the expertise and thick wallets
necessary to back startups that are at once risky and rich with potential for lucrative returns.
Eli Lilly and Co. won a U.S. court ruling Wednesday that bars Teva Pharmaceutical Industries Ltd. from selling a generic version
of the cancer drug Gemzar until November.
Eli Lilly and Co.’s Alimta has received the preliminary backing of a United Kingdom agency as a maintenance treatment for
patients with the most common form of lung cancer.
The biggest chance Brad Stevens ever took, the best game plan he ever drew up, had nothing to do with a prized recruit or
some brilliant set of Xs and Os scrawled out on a greaseboard. It came on the day he decided to quit his job at Eli Lilly
and
Co. and to pursue his first love, basketball.
Lilly’s lobbying spending represents a 36-percent drop from the final quarter of 2008, even though the Congressional debate
over health care reform peaked during the last quarter of 2009.
Deal with unit of Massachusetts-based Thermo Fisher Scientific would keep many of the employees working in same
location.
The site, created by TrendyMinds, is aimed at out-of-town job candidates, who might be unaware of the city’s cultural
and entertainment offerings.
Vonnegut Memorial Library Inc. will move into 1,100 square feet at 340 N. Senate Ave. The Arts Council of Indianapolis will
occupy 5,400 square feet at 922 N. Pennsylvania St.
Eli Lilly is interested in assets that may be offered for sale as a result of Sanofi-Aventis SA and Merck & Co.’s plan to
combine their veterinary units.
Indianapolis-based Eli Lilly and Co. sued rival drugmaker Hospira Inc. to prevent it from selling a generic version of the
cancer drug Gemzar before a patent on the medicine expires in 2013.
Once the nation’s wealthiest foundation, Indianapolis-based Lilly Endowment now ranks ninth among its grant-making
peers. The endowment’s value fell 15 percent last year, to an estimated $4.8 billion.
John Lechleiter, CEO of Eli Lilly and Co., was elected treasurer of the board of PhRMA, the powerful industry
association that represents large pharmaceutical and biotech companies. Lechleiter has been on the board of PhRMA for two
years.
Indianapolis-based Simon Property Group Inc. named former WellPoint Inc. CEO Larry Glasscock to its board
of directors. Glasscock, 61, also serves as a director at Warsaw-based Zimmer Holdings Inc. and Sprint Nextel Corp.
The Indiana Health Industry Forum elected two members to its board of directors: Mark Deuser, CEO of Techshot,
a technology development company based in Greenville, and Todd Vare, an intellectual-property attorney at
the Indianapolis law firm Barnes & Thornburg LLP.
You win some, you lose some, and you go to court again. That was the story for Eli Lilly and Co. in the
past week. The Indianapolis-based drugmaker suffered the biggest theft of pharmaceuticals in history when $75 million worth
of drugs were stolen from a Connecticut warehouse. The company expects its insurance to cover the losses. Meanwhile, Lilly
won a court appeal against Massachusetts-based Ariad Pharmaceuticals Inc., according to Bloomberg News. That decision nullified
a $65.2 million verdict won by Ariad for royalties on Lilly’s osteoporosis drug Evista and sepsis medicine Xigris. But
Lilly plunged into a new patent dispute, this time suing the U.S. unit of Dutch drugmaker Synthon BV to prevent it from selling
a generic version Adcirca. The drug, which was approved last year, uses the same active ingredient as Lilly’s anti-impotence
pill Cialis to treat lung problems.
The Fairbanks Institute for Healthy Communities has created a repository in Indianapolis for scientists
to research diseases associated with aging and ideally help develop more effective medicines. The INbank stores biological
samples along with the history and clinical outcome of the corresponding patient.
The Alfred Mann Institute for Biomedical Development in West Lafayette is funding work by two Purdue University
professors that could allow for almost immediate readings on the concentration of a drug in a patient’s blood. The technology,
being developed by Zheng Ouyang, a professor of biomedical engineering, and R. Graham Cooks, an analytical chemistry professor,
could be used in hospitals, doctor's offices or as part of clinical trials. Also, by not sending the blood sample to an
off-site lab, the test could cost far less.
Indianapolis-based Diversity Accords LLC and the Indiana Health Industry Forum have formed
a partnership to help minority-owned suppliers identify and respond to opportunities within the health and life sciences industries.
Members of the Health Industry Forum can receive a discount off Diversity Accords’ monthly association fee. Diversity
Accords has been tapped by such companies as Illinois-based Hospira Inc. and California-based Kaiser-Permanente to meet their
objectives on using minority-owned companies as suppliers.
Monday’s decision throws out a $65.2 million patent-infringement verdict won by Ariad for royalties on Lilly’s osteoporosis
drug Evista and sepsis medicine Xigris.
Sweeping changes phase in slowly for most, but insurers, hospitals, drug companies, employers, workers, medical device makers
and more will eventually feel impact.
